Pediatrix Medical (MD) Long-Term Deferred Tax (2018 - 2026)

Pediatrix Medical (MD) has 9 years of Long-Term Deferred Tax data on file, last reported at $65.7 million in Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $65.7 million, down 33.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $65.7 million (down 33.88% YoY), and the FY2025 annual result was $73.9 million, down 69.63% from the prior year.
• Long-Term Deferred Tax slipped to $65.7 million in Q1 2026 per MD's latest filing, from $73.9 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $696.6 million in Q4 2022 and troughed at $65.7 million in Q1 2026.
• A 5-year average of $137.9 million and a median of $99.4 million in 2025 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax tumbled 90.17% in 2023, then soared 255.34% in 2024.
• A 5-year view of Long-Term Deferred Tax shows it stood at $696.6 million in 2022, then plunged by 90.17% to $68.5 million in 2023, then soared by 255.34% to $243.4 million in 2024, then slumped by 69.63% to $73.9 million in 2025, then fell by 11.11% to $65.7 million in 2026.
• Business Quant data shows MD's Long-Term Deferred Tax at $65.7 million in Q1 2026, $73.9 million in Q4 2025, and $79.8 million in Q3 2025.